Skip to main content

Table 4 Variation in glucose levels and inflammatory status

From: Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention

  Reduced LVEF group
(n = 48)
Normal LVEF group
(n = 253)
P value
Pre-PCI    
Diabetes, n (%) 24 (50.0%) 77 (30.4%) 0.008
Prediabetes, n (%) 0 (0.00%) 7 (2.8%) 0.520
Normoglycaemic, n (%) 24 (50.0%) 169 (66.8%) 0.026
Glucose level at admission, mmol/L 6.70 (3.14) 5.54 (1.64) 0.001
CRP, mg/L 5.23 (8.94) 1.69 (4.51)  < 0.001
Follow-up    
Diabetes, n (%) 24 (50.0%) 77 (30.4%) 0.008
Prediabetes, n (%) 1 (2.1%) 10 (4.0%) 0.831
Normoglycaemic, n (%) 23 (47.9%) 166 (65.6%) 0.020
Glucose level at follow-up, mmol/L 6.12 (3.04) 5.42 (1.36) 0.001
Follow-up CRP, mg/L 1.37 (3.10) 0.97 (2.49) 0.012
Decreasing glucose level  − 0.12 (2.59)  − 0.05 (1.42) 0.944
  1. Values are mean ± standard deviation, medians (interquartile range), or n (%)
  2. LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; CRP, C-reactive protein